Literature DB >> 18325617

Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres.

Qingguo Xu1, Jan T Czernuszka.   

Abstract

Negatively charged poly(lactic-co-glycolic acid) (PLGA) microspheres with an encapsulated hydrophilic antibiotic (amoxicillin) have been prepared by the solid-in-oil-in-water (s/o/w) method using the anionic surfactant, sodium dodecyl sulfate (SDS). Drug encapsulation efficiency is over 40%. Successful coating of hydroxyapatite (HA) on these negatively charged PLGA microspheres has been achieved by a dual constant composition method in 3-6 h. The HA-coated PLGA microspheres (HPLG) have been characterised by zeta-potential and particle size measurements and the coating has been confirmed to be calcium deficient HA by analysis of X-ray diffraction, Fourier transform infrared spectroscopy and wavelength dispersive spectroscopy. The morphology of HPLG was studied by scanning electron microscopy, and cross sections of HPLG microspheres were prepared and imaged using focused ion beam microscopy. In-vitro drug release experiments in PBS (pH7.4) showed a sustained release profile for at least 31 days with little initial burst release. It shows a triphasic drug release profile commonly observed for biodegradable polymers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325617     DOI: 10.1016/j.jconrel.2008.01.017

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  24 in total

1.  A controlled release of antibiotics from calcium phosphate-coated poly(lactic-co-glycolic acid) particles and their in vitro efficacy against Staphylococcus aureus biofilm.

Authors:  Kelsen Bastari; Mohamed Arshath; Zhi Hui Melissa Ng; Jia Hua Chia; Zhi Xian Daniel Yow; Barindra Sana; Meng Fong Cherine Tan; Sierin Lim; Say Chye Joachim Loo
Journal:  J Mater Sci Mater Med       Date:  2013-12-27       Impact factor: 3.896

2.  Droplet based microfluidic fabrication of designer microparticles for encapsulation applications.

Authors:  Tiantian Kong; Jun Wu; Michael To; Kelvin Wai Kwok Yeung; Ho Cheung Shum; Liqiu Wang
Journal:  Biomicrofluidics       Date:  2012-07-20       Impact factor: 2.800

Review 3.  Organic-inorganic composites for bone drug delivery.

Authors:  Chidambaram Soundrapandian; Biswanath Sa; Someswar Datta
Journal:  AAPS PharmSciTech       Date:  2009-10-20       Impact factor: 3.246

Review 4.  Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.

Authors:  Viviana Mouriño; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

5.  Silver nanoparticle deposited implants to treat osteomyelitis.

Authors:  Samit Kumar Nandi; Anish Shivaram; Susmita Bose; Amit Bandyopadhyay
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2017-05-15       Impact factor: 3.368

Review 6.  Nanomedicine for safe healing of bone trauma: Opportunities and challenges.

Authors:  Shahed Behzadi; Gaurav A Luther; Mitchel B Harris; Omid C Farokhzad; Morteza Mahmoudi
Journal:  Biomaterials       Date:  2017-09-04       Impact factor: 12.479

7.  Preparation, characterization, and release of amoxicillin from electrospun fibrous wound dressing patches.

Authors:  Panagiotis Sofokleous; Eleanor Stride; Mohan Edirisinghe
Journal:  Pharm Res       Date:  2013-04-25       Impact factor: 4.200

8.  Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.

Authors:  Daniel J Hines; David L Kaplan
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2013       Impact factor: 4.889

9.  A novel nano drug delivery system based on tigecycline-loaded calciumphosphate coated with poly-DL-lactide-co-glycolide.

Authors:  Nenad L Ignjatović; Petar Ninkov; Roya Sabetrasekh; Dragan P Uskoković
Journal:  J Mater Sci Mater Med       Date:  2009-08-26       Impact factor: 3.896

Review 10.  Nanoparticulate drug delivery platforms for advancing bone infection therapies.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  Expert Opin Drug Deliv       Date:  2014-08-11       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.